Rheumatoid Arthritis, Psoriatic Arthritis & Axial Spondyloarthritis
Dosing with Enbrel® can be individualised based on the needs of each patient.1
The recommended dose of Enbrel® for adult patients with RA, PsA and axSpA (AS) is1:
Adapted from Enbrel® LPD. Version LPDENB062021.
In patients with PsA and axSpA (AS), available data suggest that a clinical response is usually achieved within 12 weeks of treatment. Continued therapy should be carefully reconsidered in patients not responding within this time period.1
AS, ankylosing spondylitis; axSpA, axial spondyloarthritis; BIW, twice a week; PsA, psoriatic arthritis; QW, once a week; RA, rheumatoid arthritis; TNFR, tumour necrosis factor receptor.
Detectable ADAbs may reduce the response of TNFi therapy
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered Medical Practitioner*, please visit
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.
PP-UNP-IND-0012 July 2022